ArticleFrontiers in oncology2026

Targeting RAC1 in glioblastoma: prognostic value, immune landscape, and small molecule therapeutic potential.

Qionghui Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.